Human family with sequence similarity 83, member A

Entry Clone Source: MGC

Entry Clone Accession: BC052300

SGC Construct ID: FAM83AA-c008

Construct DNA sequence:

ATGAGCCGGTCAAGGCACCTGGGCAA
AATCCGGAAGCGTCTGGAAGATGTCA
AGAGCCAGTGGGTCCGGCCAGCCAGG
GCTGACTTTAGTGACAACGAGAGTGC
CCGGCTGGCCACGGACGCCCTCTTGG
ATGGGGGTTCTGAAGCCTACTGGCGG
GTGCTCAGCCAGGAAGGCGAGGTGGA
CTTCTTGTCCTCGGTGGAGGCCCAGT
ACATCCAGGCCCAGGCCAGGGAGCCC
CCGTGTCCCCCAGACACCCTGGGAGG
GGCGGAAGCAGGCCCTAAGGGACTGG
ACTCCAGCTCCCTACAGTCCGGCACC
TACTTCCCTGTGGCCTCAGAGGGCAG
CGAGCCGGCCCTACTGCACAGCTGGG
CCTCAGCTGAGAAGCCCTACCTGAAG
GAAAAATCCAGCGCCACTGTGTACTT
CCAGACCGTCAAGCACAACAACATCA
GAGACCTCGTCCGCCGCTGCATCACC
CGGACTAGCCAGGTCCTGGTCATCCT
GATGGATGTGTTCACGGATGTGGAGA
TCTTCTGTGACATTCTAGAGGCAGCC
AACAAGCGTGGGGTGTTCGTTTGTGT
GCTCCTGGACCAGGGAGGTGTGAAGC
TCTTCCAGGAGATGTGTGACAAAGTC
CAGATCTCTGACAGTCACCTCAAGAA
CATTTCCATCCGGAGTGTGGAAGGAG
AGATATACTGTGCCAAGTCAGGCAGG
AAATTCGCTGGCCAAATCCGGGAGAA
GTTCATCATCTCGGACTGGAGATTTG
TCCTGTCTGGATCTTACAGCTTCACC
TGGCTCTGCGGACACGTGCACCGGAA
CATCCTCTCCAAGTTCACAGGCCAGG
CGGTGGAGCTGTTTGACGAGGAGTTC
CGCCACCTCTACGCCTCCTCCAAGCC
TGTGATGGGCCTGAAGTCCCCGCGGC
TGGTCGCCCCCGTCCCGCCCGGAGCA
GCCCCGGCCAATGGCCGCCTTAGCAG
CAGCAGTGGCTCCGCCAGTGACCGCA
CGTCCTCCAACCCCTTCAGCGGCCGC
TCGGCAGGCAGCCACCCCGGTACCCG
AAGTGTGTCCGCGTCTTCAGGGCCCT
GTAGCCCCGCGGCCCCACACCCGCCT
CCACCGCCCCGGTTCCAGCCCCACCA
AGGCCCTTGGGGAGCCCCGAGTCCCC
AGGCCCACCTCTCCCCGCGGCCCCAC
GACGGCCCGCCCGCCGCTGTCTACAG
CAACCTGGGGGCCTACAGGCCCACGC
GGCTGCAGCTGGAGCAGCTGGGCCTG
GTGCCGAGGCTGACTCCAACCTGGAG
GCCCTTCCTGCAGGCCTCCCCTCACT
TCTGA

Expressed protein sequence:

MHHHHHHSSGVDLGTENLYFQSMASA
EKPYLKEKSSATVYFQTVKHNNIRDL
VRRCITRTSQVLVILMDVFTDVEIFC
DILEAANKRGVFVCVLLDQGGVKLFQ
EMCDKVQISDSHLKNISIRSVEGEIY
CAKSGRKFAGQIREKFIISDWRFVLS
GSYSFTWLCGHVHRNILSKFTGQAVE
LFDEEFRHLYASSKPVMGLKSPRL

Vector:pNIC28-Bsa4

Tags and additions: MGHHHHHHSSGVDLGTENLYFQ*SM. cleavable N-terminal hexahistidine tag.

Host: BL21(DE3)-R3-pRARE2.

Growth medium, induction protocol:

A glycerol stock was used to inoculate a 30 ml starter culture containing LB media and 50 µg/ml kanamycin. The starter culture was grown overnight at 37°C with shaking at 250 rpm. Three flasks each containing 1L LB media with 50 µg/ml kanamycin were inoculated with 10 ml of the starter culture. The 1L cultures were incubated at 37°C with shaking at 160 rpm until an OD600nm ≥ 0.5 was reached. The flasks were then cooled down to 18°C and 0.4 mM IPTG added to induce protein expression overnight. Cells were harvested by centrifugation at 4500 rpm at 4°C for 15 min. The cell pellet was resuspended in 30 ml binding buffer (50 mM Hepes, pH 7.5; 500 mM NaCl; 5% Glycerol; 5 mM imidazole), transferred to a 50 ml tube, and stored at -20°C.

Extraction buffer, extraction method: The frozen cells were thawed and the volume increased to 80 ml with binding buffer. The cells were lysed by sonication over 12 min with the sonicator pulsing ON for 5 sec and OFF for 10 sec. The DNA was precipitated using 0.15% PEI (polyethyleneimine) pH 8. The cell lysate was spun down by centrifugation at 21.5K rpm at 4°C for 1 h. The supernatant was recovered for purification.

Column 1: Ni-Affinity Chromatography. 5 ml of 50 % Ni-sepharose slurry was applied onto a 1.5 x 10 cm column. The column was equilibrated with binding buffer (25ml).

Buffers:

Binding buffer: 50 mM Hepes, pH 7.5; 500 mM NaCl; 5% Glycerol; 5 mM imidazole, 0.1mM TCEP
Wash buffer: 50 mM Hepes, pH 7.5; 500 mM NaCl; 5% Glycerol; 25 mM imidazole, 0.1mM TCEP
Elution buffer: 50 mM HEPES, pH 7.5; 500 mM NaCl; 5% Glycerol; 50 to 250 mM imidazole, 0.1mM TCEP

Procedure:

The supernatant was applied by gravity flow onto the Ni-sepharose column. The bound protein was eluted by applying a step gradient of imidazole – using 5 ml portions of elution buffer with increasing concentration of imidazole (50 mM, 100 mM, 150 mM, 250 mM).

Enzymatic treatment: 0.1mg of TEV protease was added to the Ni-eluted protein to remove the tag.

Column 2:Size Exclusion Chromatography – S200 HiLoad 16/60 Superdex run on ÄKTA-Express

Buffer:
Gel Filtration buffer: 300 mM NaCl, 50 mM Hepes pH 7.5, 0.5mM TCEP

Procedure: Prior to applying the protein, the S200 16/60 column was washed and equilibrated with gel filtration buffer. The protein was concentrated to 4 ml using an Amicon Ultra-15 filter with a 10 kDa cut-off. The concentrated protein was directly applied onto the equilibrated S200 16/60 column, and run at a flow-rate of 1 ml/min. The protein was eluted at 96 – 110 ml. Fractions containing the protein were pooled together.

Mass spec characterization: The purified protein was homogeneous and had an experimental mass of 21137.8 (after TEV cleavage), closely matching the expected mass 21137.6. Mass was determined by LC-MS, using an Agilent LC/MSD TOF system with reversed-phase HPLC coupled to electrospray ionisation and an orthogonal time-of-flight mass analyser. Proteins were desalted prior to mass spectrometry by rapid elution off a C3 column with a gradient of 5-95% isopropanol in water with 0.1% formic acid.

Crystallization: Protein was buffered in 50 mM HEPES pH 7.5, 300 mM NaCl. The protein was concentrated to 12 mg/ml (calculated using an extinction co-efficient of 18450). Crystals were grown at 20 °C in 150 nl sitting drops mixing 75 nl protein solution with 75 nl of a reservoir solution containing 0.8M sodium phosphate monobasic, 0.8M potassium phosphate dibasic and 0.1M HEPES pH 7.5. On mounting crystals were cryoprotected with mother liquor plus 25% ethylene glycol before transfer to liquid nitrogen.

Data Collection: Resolution: 2.68Å resolution

X-ray source: Diamond Light Source, station I03